Similar articles

• Effect of betamethasone valerate on the normal human facial skin flora.

  Daltrey DC, Cunliffe WJ. Daltrey DC, et al. Acta Derm Venereol. 1983;63(2):160-2. Acta Derm Venereol. 1983. PMID: 6189335 Clinical Trial.
• Diprosone (betamethasone dipropionate) cream 0.05%. A review and interim report of a comparative multi-centre study versus betamethasone valerate 0.1%.

  Rhodes EL, Scott LV. Rhodes EL, et al. Br J Clin Pract. 1983 Apr;37(4):130-2. Br J Clin Pract. 1983. PMID: 6349670 Clinical Trial. No abstract available.
• Metabolism and degradation of betamethasone 17-valerate in homogenized living skin equivalent.

  Kubota K, Ademola J, Maibach HI. Kubota K, et al. Dermatology. 1994;188(1):13-7. doi: 10.1159/000247077. Dermatology. 1994. PMID: 8305748
• Simultaneous diffusion and metabolism of betamethasone 17-valerate in the living skin equivalent.

  Kubota K, Ademola J, Maibach HI. Kubota K, et al. J Pharm Sci. 1995 Dec;84(12):1478-81. doi: 10.1002/jps.2600841215. J Pharm Sci. 1995. PMID: 8748331
• Comparison of betamethasone dipropionate (0.05%) and betamethasone valerate (0.1%) ointments in psoriasis and other dermatoses--a multicentric double-blind clinical study.

  Sharma SD. Sharma SD. Indian J Dermatol. 1986 Apr-Jul;31(2-3):34-7. Indian J Dermatol. 1986. PMID: 3327820 Clinical Trial. No abstract available.